Inhibition of hepatitis C virus-directed gene expression by a DNA ribonuclease

Journal of Hepatology

Volumn 31, Issue 4, 1999, Pages 628-634

  Oketani, Makoto ^a   Asahina, Yasuhiro ^a   Wu, Catherine H ^a   Wu, George Y ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Department of Medicine   (United States)

Author keywords

DNA enzyme; DNA ribonuclease; Gene therapy; HCV

Indexed keywords

RIBONUCLEASE;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; GENE EXPRESSION REGULATION; GENE THERAPY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA STRUCTURE; VIRUS GENOME;

EID: 0032865553     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80341-9     Document Type: Article

References (28)

1. Tsukiyama-Kohara K, Iizuke N, Kohara M, Nomoto A. Internal ribosomal binding site within hepatitis C virus RNA. J Virol. 66:1992;1476-1483.
2. Wang C, Sarnow P, Siddiqui A. Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome binding mechanism. J Virol. 67:1993;3338-3344.
3. Bukh J, Purcell RH, Miller RH. Sequence analysis of the 5′ noncoding region of hepatitis C virus. Proc Natl Acad Sci USA. 89:1992;4942-4946.
4. Wu CH, Wu GY. Targeted inhibition of hepatitis C virus-directed gene expression in human hepatoma cell lines. Gastroenterology. 114:1998;1304-1312.
5. Sakamoto N, Wu CH, Wu GY. Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J Clin Invest. 98:1996;2720-2729.
6. Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA. 94:1997;4262-4266.
7. Asahina Y, Ito Y, Wu CH, Wu GY. DNA ribonucleases that are active against intracellular hepatitis B viral RNA targets. Hepatology. 28:1998;547-554.
8. Dash BC, Harikrishnan TA, Goia R, Shahi S, Unwalla H, Husain S, et al. Targeted cleavage of HIV-1 envelope gene by a DNA enzyme and inhibition of HIV-1 envelope-CD4 mediated cell fusion. FEBS Lett. 431:1998;395-399.
9. Bertrand E, Pictet R, Grange T. Can hammerhead ribozymes be efficient tools to inactivate gene function? Nucleic Acids Res. 22:1994;293-300.
10. Wang C, Siddiqui A. Structure and function of the hepatitis C virus internal ribosome entry site. Curr Top Microbiol Immunol. 203:1995;99-105.
11. Seki M, Honda Y. Phosphorothioate antisense oligonucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay. J Biochem. 118:1995;1199-1204.
12. Alt M, Renz R, Hofschneider PH, Paumgartner G, Caselmann WH. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligonucleotides. Hepatology. 22:1995;707-717.
13. Hanecak R, Brown-Driver V, Fox MC, Azad RF, Furusako S, Nozaki C, et al. Antisense inhibition of hepatitis C virus gene expression in transformed hepatocytes. J Virol. 70:1996;5203-5212.
14. Fedor MJ, Uhlenbeck OC. Substrate sequence effects on "hammerhead" RNA catalytic efficiency. Proc Natl Acad Sci USA. 87:1990;1668-1672.
15. Heidenreich O, Eckstein F. Hammerhead ribozymes-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J Biol Chem. 267:1992;1904-1909.
16. Xing Z, Whitton JL. Ribozymes which cleave arenavirus RNAs: identification of susceptible target sites and inhibition by target site secondary structure. J Virol. 66:1992;1361-1369.
17. Shaw JP, Kent K, Bird J, Fishback J, Froehler B. Modified deoxyoligonucleotides stable to exonuclease degradation in serum. Nucleic Acids Res. 19:1991;747-750.
18. Hoke GD, Draper K, Freier SM, Gonzalez C, Driver VB, Zounes MC, et al. Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Res. 19:1991;5743-5748.
19. Marcus SC, Woerner AM, Shinozuka K, Zon G, Quinnan GJ. Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages. Nucleic Acids Res. 15:1987;5749-5763.
20. Froehler B, Ng P, Matteucci M. Phosphoramide analogues of DNA:synthesis and thermal stability of heteroduplexes. Nucleic Acids Res. 16:1988;4831-4839.
21. Stein CA, Subasinghe C, Shinozuka K, Cohen JS. Physicochemical properties of phosphorothioate oligonucleotides. Nucleic Acids Res. 16:1988;3209-3221.
22. Heidenreich O, Benseler F, Fahrenholz A, Eckstein F. High activity and stability of hammerhead ribozymes containing 2′-modified pyrimidine nucleotides and phosphorothioates. J Biol Chem. 269:1994;2131-2138.
23. Heidenreich O, Kang SH, Brown DA, Xu X, Swiderski P, Rosssi JJ, et al. Ribozyme-mediated RNA degradation in nuclei suspension. Nucleic Acids Res. 23:1995;2223-2228.
24. Jarvis TC, Wincott FE, Alby LJ, McSwiggen JA, Beigelman L, Gustofson J, et al. Optimizinig the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb. J Biol Chem. 271:1996;29107-29112.
25. Ruffner DE, Uhlenbeck OC. Thiophosphate interference experiments locate phosphates important for the hammerhead RNA self-cleavage reaction. Nucleic Acids Res. 18:1990;6025-6029.
26. Shimayama T, Nishikawa F, Nishikawa S, Taira K. Nuclease-resistant chimeric ribozymes containing deoxyribonucleotides and phosphorothioate linkages. Nucleic Acids Res. 21:1993;2605-2611.
27. Brown EA, Zhang H, Ping L-H, Lemon SM. Secondary structure of the 5′ nontranslated regions of hepatitis C virus and pestivirus genomic RNAs. Nucleic Acids Res. 20:1992;5041-5045.
28. Wang C, Le SY, Ali N, Siddiqui A. An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5′ noncoding region. RNA. 1:1995;526-537.